A VHH single-domain platform enabling discovery and development of monospecific antibodies and modular neutralizing bispecifics against SARS-CoV-2 variants is a research paper published in Antibody Therapeutics (2024). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: R01AI132633
NIH
Grant: R24AI120942
NIH
Grant: HHS 75N93019C00073
NIAID NIH HHS
Grant: 75N93019C00073
National Institutes of Health
Grant: 5R24AI120942-05
World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
National Institutes of Health
Grant: 5R01AI132633-04
Dissecting the receptor-mediated infection mechanisms of hantaviruses
Twist Bioscience Corporation
Fields of Study
Keywords